COVID 19 News and Research

RSS

Highly effective and safe Zika vaccine technology

Scientists from the University of California, Los Angeles (UCLA) have discovered a Zika vaccine technology that is very safe and effective in preclinical mouse models.

29 Sep 2022

Tiny DNA strand net in a low-cost test platform traps COVID-19 virus

According to a new study, tiny nets made of DNA strands can capture the spike protein of the virus that causes COVID-19, illuminating it for a quick yet accurate diagnostic test and preventing it from infecting cells, suggesting a new potential path to antiviral treatment.

26 Sep 2022

Studying cell membranes’ role in allowing viruses’ spike proteins to infect cells

University of Alberta’s study demonstrates the way cell membranes perform a much bigger role than that was understood in enabling spike proteins on viruses to affect cells.

19 Sep 2022

New study supports bradykinin storm theory of COVID-19's viral pathogenesis

A new paper published in Nature Communications adds further evidence to the bradykinin storm theory of COVID-19's viral pathogenesis -; a theory that was posited two years ago by a team of researchers at the Department of Energy's Oak Ridge National Laboratory.

19 Sep 2022

Therapeutic mRNAs do not significantly impact translational fidelity

Synthetic mRNA therapeutics for the treatment and prevention of disease has attracted a lot of interest due to the exceptional efficacy of mRNA vaccinations against SARS-CoV-2.

30 Aug 2022

Breadfruit cultivation shows potential to contribute to climate-resilient food systems

In the face of climate change, breadfruit soon might come to a dinner plate near you.

18 Aug 2022

New technique reveals how environmental changes affect the dynamic structures of RNAs in living cells

The impact of environmental conditions on the dynamic structures of RNAs in living cells has been revealed by innovative technology developed by researchers at the John Innes Centre.

18 Aug 2022

Liberibacter species closely related to deadly citrus greening disease mutating rapidly

A bacterial species closely related to deadly citrus greening disease is rapidly evolving its ability to infect insect hosts, and possibly plants as well.

16 Aug 2022

Mount Sinai and Regeneron Genetics Center launch a large-scale genome sequencing project

Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai have launched a new human genome sequencing research project called the Mount Sinai Million Health Discoveries Program with the Regeneron Genetics Center (RGC), part of the industry-leading, New York-based biotechnology company Regeneron.

12 Aug 2022

Scientists solve how RNA molecules reach their targets

Scientists claim that life does not come with an instruction manual, but this is not totally accurate. Each cell in our body follows the instructions provided by its DNA in the form of RNA molecules.

1 Aug 2022

COVID-19 spike protein caused severe heart damage, new research shows

Heart damage is prevalent in COVID-19 patients, leading many to doubt how the virus impacts the heart.

28 Jul 2022

New biosensor could achieve the speed, efficiency required for COVID-19 testing in future

As the BA.5 omicron variant continues to spread, health experts are increasingly preparing for a future in which such COVID-19 variants emerge, surge and recede similar to seasonal flu.

22 Jul 2022

Researchers analyze eight assemblers on viral sequencing data

On actual viral next-generation sequencing data, a recent study compares and evaluates eight de novo genome assembly software tools.

22 Jul 2022

Researchers create antibodies against the SARS-CoV-2 from hen eggs

Scientists at the University of California, Davis, have created antibodies against the SARS-CoV-2 spike protein in hen eggs.

14 Jul 2022

SARS-CoV-2 surrogates might thrive on refrigerated or frozen meat for a month

SARS-CoV-2 surrogates can persist for up to 30 days on meat items stored in the freezer or refrigerator.

14 Jul 2022

Researchers work on DNA-delivered antibodies to stop COVID-19

A new COVID-19 antibody delivery approach has progressed to clinical trials, thanks to funding from the Defense Advanced Research Projects Agency (DARPA) and the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND).

11 Jul 2022

Challenges in Drug Discovery; Where are we now, and where are we going?

As part of our SLAS Europe 2022 coverage, we speak to Steve Rees, Vice-President of Discovery Biology at AstraZeneca, about the challenges currently faced by the drug discovery sector.

From Society for Laboratory Automation and Screening (SLAS) 8 Jul 2022

Researchers investigate dynamics and modifications of COVID-19 virus spike protein

When the coronavirus that causes COVID-19 infects human cells, the cell’s protein-processing machinery modifies the spike protein, making it more flexible and mobile, potentially increasing its possibility to contaminate other cells and evade antibodies, according to new research from the University of Illinois Urbana-Champaign.

8 Jul 2022

COVID-19 vaccination stimulates antibodies aiming parts of virus spike protein among corona variants, researchers discover

Can the SARS-CoV-2 vaccine reactivate previously suppressed antibody responses and pave the way for a unified coronavirus vaccine?